- Home
- CERS vs HYI Comparison
CERS vs HYI Comparison
Compare CERS & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- HYI
- Stock Information
- Founded
- CERS 1991
- HYI 2010
- Country
- CERS United States
- HYI United States
- Employees
- CERS N/A
- HYI N/A
- Industry
- CERS EDP Services
- HYI Investment Managers
- Sector
- CERS Technology
- HYI Finance
- Exchange
- CERS Nasdaq
- HYI Nasdaq
- Market Cap
- CERS 277.2M
- HYI 272.0M
- IPO Year
- CERS 1997
- HYI N/A
- Fundamental
- Price
- CERS $1.39
- HYI $11.90
- Analyst Decision
- CERS Strong Buy
- HYI
- Analyst Count
- CERS 2
- HYI 0
- Target Price
- CERS $3.50
- HYI N/A
- AVG Volume (30 Days)
- CERS 1.1M
- HYI 50.6K
- Earning Date
- CERS 08-05-2025
- HYI 01-01-0001
- Dividend Yield
- CERS N/A
- HYI 9.59%
- EPS Growth
- CERS N/A
- HYI N/A
- EPS
- CERS N/A
- HYI N/A
- Revenue
- CERS $185,144,000.00
- HYI N/A
- Revenue This Year
- CERS $20.97
- HYI N/A
- Revenue Next Year
- CERS $15.55
- HYI N/A
- P/E Ratio
- CERS N/A
- HYI N/A
- Revenue Growth
- CERS 13.06
- HYI N/A
- 52 Week Low
- CERS $1.12
- HYI $10.99
- 52 Week High
- CERS $2.54
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- CERS 48.50
- HYI 45.70
- Support Level
- CERS $1.35
- HYI $11.87
- Resistance Level
- CERS $1.47
- HYI $12.00
- Average True Range (ATR)
- CERS 0.07
- HYI 0.06
- MACD
- CERS -0.01
- HYI -0.02
- Stochastic Oscillator
- CERS 22.73
- HYI 33.15
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.